An observational study in Surgical Procedure, Unspecified and Intensive Care Units (ICUs), sponsored by Medtronic - MITG. Active, not recruiting at 1 site in Canada. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-10-15.
Sponsored by Medtronic - MITG (part of Medtronic) · Observational
To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - in hospital and at-home, in patients undergoing non-cardiac surgery.
Medtronic - MITG is the lead sponsor of 179 studies on the registry; 5 are open to participants now.
Of its 17 completed or terminated interventional studies of FDA-regulated products, 17 (100%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients that have undergone a non-cardiac surgery requiring an inpatient hospital stay and peri-op patients who are in the Surgical High Acuity Unit (SHAU) at SPH.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Collect patient and clinicians' feedback about the CCPC Platform
This will be completed via an assessment of the quantitative data on how long and how often patients use this monitoring and what were the reasons that patients took the monitors on and off.
Time frame: From enrollment to the end of follow up at 10 days
Confirm the technical goals of the CCPC platform are met.
This will be completed by ensuring clinical workflow is met when using the monitoring platform.
Time frame: From enrollment to the end of follow up at 10 days
Collect patient and clinicians' feedback about the CCPC Platform
This will be completed via an assessment of the Usability questionnaires.
Time frame: From enrollment to the end of follow up at 10 days
Collect patient and clinicians' feedback about the CCPC Platform
This will be completed by an evaluation of potential harm, adverse events and safety issues.
Time frame: From enrollment to the end of follow up at 10 days
Confirm the technical goals of the CCPC platform are met.
This will be completed via an assessment of the data flow: does the correct patient vitals information reach the clinicians at the right time?
Time frame: From enrollment to the end of follow up at 10 days
Confirm the technical goals of the CCPC platform are met.
This will be completed by determining if the CCPC platform provided a holistic view of each patient with vitals, medication, and other collected data.
Time frame: From enrollment to the end of follow up at 10 days
Plan to share: No
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.